A detailed history of Quent Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, Quent Capital, LLC holds 126 shares of NVS stock, worth $12,404. This represents 0.0% of its overall portfolio holdings.

Number of Shares
126
Previous 126 -0.0%
Holding current value
$12,404
Previous $13,000 7.69%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 05, 2023

SELL
$80.03 - $92.81 $400 - $464
-5 Reduced 3.82%
126 $11,000
Q3 2022

Nov 10, 2022

BUY
$74.61 - $87.26 $3,730 - $4,363
50 Added 61.73%
131 $10,000
Q2 2022

Aug 08, 2022

SELL
$80.52 - $93.75 $38,649 - $45,000
-480 Reduced 85.56%
81 $7,000
Q4 2021

Feb 28, 2022

BUY
$79.7 - $88.13 $44,711 - $49,440
561 New
561 $49,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.